Evidence map›Paper›PMID 32013265›Full record

ArticleInternational journal of molecular sciences2020

miR-20b and miR-451a Are Involved in Gastric Carcinogenesis through the PI3K/AKT/mTOR Signaling Pathway: Data from Gastric Cancer Patients, Cell Lines and Ins-Gas Mouse Model.

Greta Streleckiene, Ruta Inciuraite, Simonas Juzenas, Violeta Salteniene, Ruta Steponaitiene, Ugne Gyvyte, Gediminas Kiudelis, Marcis Leja, Paulius Ruzgys, Saulius Satkauskas and 6 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Mechanisms of Natural Extracts ofInternational journal of molecular sciences · 2022
    Review
  10. Thioredoxin-Interacting Protein in Cancer and Diabetes.Antioxidants & redox signaling · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. TXNIP: A Double-Edged Sword in Disease and Therapeutic Outlook.Oxidative medicine and cellular longevity · 2022
    Review
  15. HepaticeLife · 2021
    Article
  16. Article
  17. Role of TSC1 in physiology and diseases.Molecular and cellular biochemistry · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Greta StreleckieneInstitute for Digestive Research, Academy of Medicine, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Ruta InciuraiteInstitute for Digestive Research, Academy of Medicine, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Simonas JuzenasInstitute for Digestive Research, Academy of Medicine, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Violeta SaltenieneInstitute for Digestive Research, Academy of Medicine, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Ruta SteponaitieneInstitute for Digestive Research, Academy of Medicine, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Ugne GyvyteInstitute for Digestive Research, Academy of Medicine, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Gediminas KiudelisInstitute for Digestive Research, Academy of Medicine, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Marcis LejaInstitute for Clinical and Preventive Medicine, University of Latvia, LV-1586 Riga, Latvia.
Paulius RuzgysBiophysical Research Group, Faculty of Natural Sciences, Vytautas Magnus University, LT-44404 Kaunas, Lithuania.
Saulius SatkauskasBiophysical Research Group, Faculty of Natural Sciences, Vytautas Magnus University, LT-44404 Kaunas, Lithuania.
Eugenija KupcinskieneDepartment of Biology, Faculty of Nature Sciences, Vytautas Magnus University, LT-44404 Kaunas, Lithuania.
Sabine FrankeInstitute of Pathology, Otto-von-Guericke University, 39120 Magdeburg, Germany.
Cosima ThonDepartment of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University, 39120 Magdeburg, Germany.
Alexander LinkDepartment of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University, 39120 Magdeburg, Germany.
Juozas KupcinskasInstitute for Digestive Research, Academy of Medicine, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Jurgita SkiecevicieneInstitute for Digestive Research, Academy of Medicine, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Lithuanian University of Health Sciences · LTOtto-von-Guericke-Universität Magdeburg · DEVytautas Magnus University · LTRiga East University Hospital · LV

Funding

Research Council of Lithuania under the initiative of Researcher groups projects MIP-007/2014
6 · The paper itself

Abstract

Gastric cancer (GC) is one of the most common and lethal gastrointestinal malignancies worldwide. Many studies have shown that development of GC and other malignancies is mainly driven by alterations of cellular signaling pathways. MicroRNAs (miRNAs) are small noncoding molecules that function as tumor-suppressors or oncogenes, playing an essential role in a variety of fundamental biological processes. In order to understand the functional relevance of miRNA dysregulation, studies analyzing their target genes are of major importance. Here, we chose to analyze two miRNAs, miR-20b and miR-451a, shown to be deregulated in many different malignancies, including GC. Deregulated expression of miR-20b and miR-451a was determined in GC cell lines and the INS-GAS mouse model. Using Western Blot and luciferase reporter assay we determined that miR-20b directly regulates expression of

Indexed as

Signal TransductionAnimalsAntagomirsApoptosisCarrier ProteinsCaveolin 1Cell Line, TumorDisease Models, AnimalFemaleHumansMaleMiceMicroRNAsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseAntagomirsCarrier ProteinsCAV1 protein, humanCaveolin 1MicroRNAsMIRN20b microRNA, humanMIRN451 microRNA, humanMTOR protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseTOR Serine-Threonine KinasesTSC1 protein, humanTuberous Sclerosis Complex 1 ProteinTXNIP protein, humangastric cancermicroRNAsmiR-20bmiR-451aPI3K/AKT/mTOR signaling pathway

Identifiers

PMID32013265
PMCPMC7038213
OpenAlexW3003677250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.